LI
BIIB icon

LRI Investments’s Biogen BIIB Stock Holding History

LRI Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
514
+181
+54% +$34.6K 0.01% 430
2026
Q1 		$61.1K Buy
333
+281
+540% +$51.8K 0.01% 483
2025
Q4 		$9.13K Buy
52
+46
+767% +$7.51K ﹤0.01% 897
2025
Q3 		$840 Hold
6
– – ﹤0.01% 1267
2025
Q2 		$754 Hold
6
– – ﹤0.01% 1227
2025
Q1 		$821 Hold
6
– – ﹤0.01% 1163
2024
Q4 		$918 Sell
6
-19
-76% -$3.21K ﹤0.01% 1114
2024
Q3 		$4.12K Sell
25
-73
-74% -$15.3K ﹤0.01% 969
2024
Q2 		$22.7K Buy
98
+92
+1,533% +$20K ﹤0.01% 586
2024
Q1 		$1.29K Buy
+6
New +$1.41K ﹤0.01% 784

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

LRI Investments's BIIB Position: Q2 2026 in Review

LRI Investments increased its Biogen (BIIB) stake by 54% in Q2 2026, buying an estimated $34.6K and bringing the position to 514 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #430.

LRI Investments first reported a position in BIIB in Q1 2024 and has held it in 10 quarters since. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • LRI Investments held 514 shares of Biogen worth $111K as of Q2 2026.
  • LRI Investments bought 181 Biogen shares in Q2 2026, an estimated $34.6K.
  • Biogen made up 0.01% of LRI Investments's portfolio in Q2 2026, its #430 holding.
  • LRI Investments first reported a position in Biogen in Q1 2024 and has held it in 10 quarters since.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.